HOSPITAL-COMMUNITY SERVICES NETWORK

UNIT HEAD
Doctor David Zucman

WHAT IS THE HOSPITAL COMMUNITY SERVICES NETWORK?

 

 

This is a functional unit of the Hôpital Foch's Internal Medicine Department which proposes multi-disciplinary (medical, psychology and social) services for patients with HIV, STD and HIV/Viral Hepatitis co-infections in liaison with their GPs.
The HCSN proposes training programs, notably DPC (career development), for healthcare professionals.

 

The HCSN also proposes HIV and STD awareness and prevention initiatives.
The HCSN participates in clinical and epidemiological HIV, STD and Viral Hepatitis research. This is through the ANRS (National Agency for HIV infection and Viral Hepatitis Research) Clinic 57 research centre. The clinical and social science research proposed by the HCSN is also implemented by the Hôpital Foch DRCI (Clinical Research and Innovation Delegation). The research fields cover: HIV and HIV-VHC/HIV-VHB treatments, HIV vaccinations and MST screening programs, etc.

 

Find out more: www.rvhvaldeseine.org

WHAT PATHOLOGIES DOES THE DEPARTMENT COVER?

 

 

  • Patients with HIV infections.
  • Individuals who have been the victims of HIV exposure incidents (professional, sexual or accidental) or presenting the signs of a sexually transmissible infection.

 

 

Consultations are possible Monday to Saturday.

Subject to the recommendations of the expert assessment, a short-stay hospitalisation in the Internal Medicine department can be organised for a summary check-up to assess all of the various health issues in liaison with the hospital's various specialists.
Where necessary a standard hospitalisation will be organised in the hospital department most suited for the conditions observed.

 

Partnerships have been set up with various community specialist services (psychiatry, therapeutic accommodation, convalescence and rehabilitation, patient support associations, treatment centres for people suffering with addictions, etc).

 

  • The HCSN proposes therapy education sessions for persons concerned by HIV to ensure treatment is monitored correctly and prevent transmission risks.
  • The HCSN proposes psychological and social services support to all individuals who request it.

USEFUL INFORMATION

 

 

Medical consultations

at the hospital by appointment (tel: 01 46 25 25 25)

 

Dr David ZUCMAN
Tel: 01 46 25 27 11 Email: d.zucman@hopital-foch.com

9am to 12:30pm, Tuesday to Friday
2nd, 4th and 5th Thursdays of each month: 9am to 12:30pm
1st and 3rd Thursdays of each month: 5pm to 8pm
2nd, 4th and 5th Saturdays of each month: 9am to 12:30pm

 

 

Dr Catherine MAJERHOLC
Tel: 01 46 25 27 11

9am to 12:30pm, Monday to Wednesday

 

 

Dr Erwan FOURN
Tel: 01 46 25 27 11

Fridays: 2pm to 5pm

 

 

Hospital presence of the AIDES Association: 1st and 3rd Thursday of each month during consultations

 

 

Therapeutic education

 

Mrs Dominique ALBUCHER
2nd and 4th Saturdays of each month before the medical consultation

 

Hospitalisation

 

Internal Medicine Department of Dr JE Kahn:

Short-stay hospital (evaluations): Yellow Sector ground floor (Healthcare executive: Mrs Laurence MICHEL) – Tel.: 01 46 25 28 06 or 01 46 25 59 89
Normal hospitalisation: First floor, North wing, Mr Eddy BONZON (Healthcare executive) 01 46 25 26 38

 

Social worker

Mrs Dominique ALBUCHER
By appointment, Tel.: 01 46 25 22 61

 

Psychologist

Mrs Isabelle PIQUAND
Call reception for an appointment: 01.46.25.21.46
Consultations: All day Wednesday and Friday mornings

 

Reception

Mrs Emmanuelle ROUSSEAU- Tel.: 01 46 25 27 11

 

Clinical research coordinator


Dr Svetlane DIMI- 01 46 25 73 54

 

COREVIH Ile-de-France-West Clinical research technician

Mrs Dominique BORNAREL- Tel.: 01 46 25 28 01

 

The Hospital-Community Services Network has an active HIV and MST prevention and awareness policy and has been proposing pre-exposure prophylaxis consultations (PrEP) since February 2016.

This is a new strategy to reduce HIV contamination through high-risk (unprotected) sexual activities. This strategy is based on the use of a drug called Truvada and has shown itself to be effective in numerous clinical trials.